Farmas USA (2775/16992)

#22193

Re: Farmas USA

07/12/12 14:45

Huele a fuego, de algunas cabezas sale humo estudiando la operativa para esta tarde...
suerte a todos y que nadie se acochine en tablas...

#22194

Re: Farmas USA

07/12/12 14:53

hello, putadon de AMRN....

empiezan las revisiones de PO, Cannacord lo baja de 26 a 19$

http://www.streetinsider.com/Analyst+Comments/Canaccord+Trims+PT+on+Amarin+%28AMRN%29%3B+Sees+Increased+Commercial+Risk%2C+Still+Positive+on+NCE/7931925.html?si_client=st

#22195

Re: Farmas USA

07/12/12 14:57

peeero sigue manteniendo BUY,

#22196

Re: Farmas USA

07/12/12 15:01

jefferies mantiene BUY y PO a 28

http://www.streetinsider.com/Analyst+Comments/Jefferies+Maintains+Bullish+Stance+on+Amarin+%28AMRN%29+Despite+Self+Commercialization+News/7931803.html?si_client=st

#22197

Re: Farmas USA

07/12/12 16:01

Yo tambien mantengo mis AMRN con all in :)

#22198

Re: Farmas USA

Prometeo13

07/12/12 16:35

AMRN Acabo de sacar del garage la tienda, el saco de dormir, el camping gas, las piketas, catimplota, cuerdas, machete......y 5k para meterle un tiro de GRACIA y esperar sentado el BO.
Tengo lo fundamental,buen precio, posibilidad de promediar acojonante y TRANQULIDAD Y PACIENCIA.

AMRN BO sure.

#22199

Re: Farmas USA

Top 10

framus_morrigan

07/12/12 16:43

NADA HA CAMBIADO

Citigroup Reiterates Buy Rating, $20 PT on Amarin Corporation
10:09a ET December 7, 2012 (Benzinga)
In a report published Friday, Citigroup reiterated its Buy rating and $20.00 price target on Amarin Corporation (NASDAQ: AMRN).

Citigroup noted, “We were not surprised by AMRN's initiation of hiring a Vascepa salesforce based on prior management guidance. However, we believe the concurrent establishment of a $100M debt instrument despite ending 3Q with $215M in cash will inject added uncertainty around both next Friday‘s (12/14) expected FDA exclusivity decision for Vascepa getting NCE, and the relative interest level of potential partners. We expect these actions to increase the nearterm speculation and volatility for AMRN shares, however our projections for Vascepa are unchanged as we previously valued AMRN based on a stand-alone scenario.”

http://www.rankia.com/foros/bolsa/respuestas/2437438-hemeroteca-biblioteca-farma

#22200

Re: Farmas USA

07/12/12 16:43

pues yo he bajado al garaje y solo he visto telarañas y goteras, así que me he puesto un casco de moto (integral, por supuesto) y he salido a atracar un par de abuelas (bueno, les he pedido "prestada" su pensión), y vamos a invertir ese dinero en Amarines a 9'50.